Gastro-Intestinal Trials

A LIST OF OUR EARLY PHASE gastro-intestinal TRIALS WHICH ARE OPEN TO RECRUITMENT AT UNIVERSITY COLLEGE LONDON HOSPITALs

To find more information on UCLH Early Phase Cancer Clinical Trials, including eligibility criteria, click the hyperlinked Local Project Reference (LRP) ID, which will take you to the UCLH Find a Study database.

TRIALS ON-HOLD TO RECRUITMENT

NuTide302 A Phase Ib open label Study to assess NUC-3373 in patients with colorectal cancer: A Phase Ib open label study to assess the safety and pharmacokinetics of NUC-3373, a nucleotide analogue, given in combination with standard agents used in colorectal cancer treatment
Local Project Reference:	108215
Principal Investigator	Dr. Khurum Khan
Drug Class/ Treatment:	NUC-3373 (Nucleotide Analogue) Part 3: Arm 3A - Combination with LV Q1W + Oxaliplatin + Bevacizumab
Patient Population:	Colorectal Cancer
Trial Hosted By - NIHR UCLH Clinical Research Facility (CRF)